Reappraisal of MMR vaccines currently used in Korea

Pediatrics International

Volumn 53, Issue 3, 2011, Pages 374-380

  Lee, Hyunju ^a   Kim, Han Wool ^a   Cho, Hye Kyung ^a   Park, Eun Ae ^a   Choi, Kyong Min ^b   Kim, Kyung Hyo ^a  

^a Ewha Womans University School of Medicine   (South Korea)

^b Kwandong University College of Medicine   (South Korea)

Author keywords

measles; measles mumps rubella vaccine; mumps; rubella; vaccines

Indexed keywords

MEASLES MUMPS RUBELLA VACCINE;

ARTICLE; BRONCHIOLITIS; CHILD; DRUG SAFETY; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; FEVER; GASTROENTERITIS; HUMAN; IMMUNIZATION; IMMUNOGENICITY; INJECTION SITE PAIN; INJECTION SITE SWELLING; IRRITABILITY; KOREA; MALE; MEASLES; MUMPS; NORMAL HUMAN; OTITIS MEDIA; PHARYNGITIS; PRESCHOOL CHILD; PRIORITY JOURNAL; RASH; RUBELLA; SEROCONVERSION; SIDE EFFECT; SINGLE DRUG DOSE; SKIN REDNESS; THROMBOCYTOPENIA; UPPER RESPIRATORY TRACT INFECTION;

CHILD; CHILD, PRESCHOOL; DISEASE OUTBREAKS; FEMALE; FOLLOW-UP STUDIES; HUMANS; INFANT; MALE; MEASLES; MEASLES-MUMPS-RUBELLA VACCINE; MUMPS; PROGNOSIS; REPUBLIC OF KOREA; RUBELLA; VACCINATION;

EID: 79959769580     PISSN: 13288067     EISSN: 1442200X     Source Type: Journal    
DOI: 10.1111/j.1442-200X.2010.03244.x     Document Type: Article

References (28)

1. th edn. Saunders, Philadelphia, 2004; 389-440.
2. th edn. Saunders, Philadelphia, 2004; 441-70.
3. th edn. Saunders, Philadelphia, 2004; 707-44.
4. Centers for Disease Control and Prevention. Elimination of measles-South Korea, 2001-2006. MMWR Morb. Mortal. Wkly Rep. 2007; 56: 304-7.
5. Dayan GH, Quinlisk MP, Parker AA, et al,. Recent resurgence of mumps in the United States. N. Engl. J. Med. 2008; 358: 1580-9. (Pubitemid 351519818)
6. Cohen C, White JM, Savage EJ, et al,. Vaccine effectiveness estimates, 2004-2005 mumps outbreak, England. Emerg. Infect. Dis. 2007; 13: 12-7. (Pubitemid 46057832)
7. Kim KH, Kim CH, Choi BY, Go UY, Lee DH, Ki M,. Mumps transmission control status and inapparent infection rate among middle and high school students during the 2007-2008 mumps outbreak in Daegu. J. Prev. Med. Public Health 2009; 42: 408-15.
8. th Annual Meeting of the European Society for Paediatric Infectious Diseases, Graz, Austria. 2008. Abstract 603.
9. Ahn SI, Chung MK, Yoo JS, et al,. The safety and immunogenicity of a trivalent, live, attenuated MMR vaccine, Priorix (TM). Korean J. Pediatr. 2005; 48: 960-8.
10. Feiterna-Sperling C, Bronnimann R, Tischer A, Stettler P, Durrer P, Gaedicke G,. Open randomized trial comparing the immunogenicity and safety of a new measles-mumps-rubella vaccine and a licensed vaccine in 12- to 24-month-old children. Pediatr. Infect. Dis. J. 2005; 24: 1083-8. (Pubitemid 43011065)
11. Lim FS, Han HH, Bock HL,. Safety, reactogenicity and immunogenicity of the live attenuated combined measles, mumps and rubella vaccine containing the RIT 4385 mumps strain in healthy Singaporean children. Ann. Acad. Med. Singapore 2007; 36: 969-73. (Pubitemid 351294179)
12. Crovari P, Gabutti G, Giammanco G, et al,. Reactogenicity and immunogenicity of a new combined measles-mumps-rubella vaccine: Results of a multicentre trial. The Cooperative Group for the Study of MMR vaccines. Vaccine 2000; 18: 2796-803. (Pubitemid 30254465)
13. Orenstein WA, Markowitz L, Preblud SR, Hinman AR, Tomasi A, Bart KJ,. Appropriate age for measles vaccination in the United States. Dev. Biol. Stand. 1986; 65: 13-21.
14. Oh SH, Kim HW, Lim Y, Lee H,. Measles antibodies measured by plaque reduction neutralization test in infants during the first year of life. Korean J. Pediatr. 2004; 47: 827-32.
15. Watson JC, Pearson JA, Markowitz LE, et al,. An evaluation of measles revaccination among school-entry-aged children. Pediatrics 1996; 97: 613-18. (Pubitemid 26138088)
16. Krugman S,. Further-attenuated measles vaccine: Characteristics and use. Rev. Infect. Dis. 1983; 5: 477-81.
17. Christenson B, Bottiger M,. Measles antibody: Comparison of long-term vaccination titres, early vaccination titres and naturally acquired immunity to and booster effects on the measles virus. Vaccine 1994; 12: 129-33. (Pubitemid 24041929)
18. Johnson CE, Kumar ML, Whitwell JK, et al,. Antibody persistence after primary measles-mumps-rubella vaccine and response to a second dose given at four to six vs. eleven to thirteen years. Pediatr. Infect. Dis. J. 1996; 15: 687-92. (Pubitemid 26271977)
19. Usonis V, Bakasenas V, Kaufhold A, Chitour K, Clemens R,. Reactogenicity and immunogenicity of a new live attenuated combined measles, mumps and rubella vaccine in healthy children. Pediatr. Infect. Dis. J. 1999; 18: 42-8. (Pubitemid 29055268)
20. Pipkin PA, Afzal MA, Heath AB, Minor PD,. Assay of humoral immunity to mumps virus. J. Virol. Methods 1999; 79: 219-25. (Pubitemid 29221995)
21. Galazka AM, Robertson SE, Kraigher A,. Mumps and mumps vaccine: A global review. Bull. World Health Organ. 1999; 77: 3-14. (Pubitemid 29282133)
22. Hersh BS, Fine PE, Kent WK, et al,. Mumps outbreak in a highly vaccinated population. J. Pediatr. 1991; 119: 187-93.
23. Cheek JE, Baron R, Atlas H, Wilson DL, Crider RD, Jr,. Mumps outbreak in a highly vaccinated school population. Evidence for large-scale vaccination failure. Arch. Pediatr. Adolesc. Med. 1995; 149: 774-8.
24. Schaffzin JK, Pollock L, Schulte C, et al,. Effectiveness of previous mumps vaccination during a summer camp outbreak. Pediatrics 2007; 120: e862-868. (Pubitemid 47549529)
25. Ong G, Goh KT, Ma S, Chew SK,. Comparative efficacy of Rubini, Jeryl-Lynn and Urabe mumps vaccine in an Asian population. J. Infect. 2005; 51: 294-8. (Pubitemid 41683869)
26. Oh SH, Kang JH, Sohn YM, Lee HJ, Pyun BY, Kim CH,. Antibody response and adverse reaction following immunization with MMR vaccine produced on human diploid cells in Korean children. J. Korean Pediatr. Soc. 2000; 43: 489-95.
27. Lee JC, Kim BI, Ahn DH, Hahn DS,. Clinical reactions and effect on the platelet count in the peripheral blood after live attenuated measles virus (Lirugen) vaccination. J. Korean Pediatr. Soc. 1969; 12: 1-6.
28. Kim JS, Koh SH, Chang SC, Kim KH,. Clinico-immunologic reaction and effect on the platelet count following measles vaccination of Schwarz strain. J. Korean Pediatr. Soc. 1969; 12: 7-12.